Oxford BioMedica PLC (OXB) — Cash Flow Reinvestment Rate
Oxford BioMedica PLC (OXB) has a Cash Flow Reinvestment Rate of 0.64x as of June 2025, reinvesting GBX1.51 Million (capex GBX1.51 Million ) from operating cash flow of GBX2.35 Million. Check earnings quality score of Oxford BioMedica PLC to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Oxford BioMedica PLC Cash Flow Reinvestment Rate (2007–2021)
Historical reinvestment intensity for Oxford BioMedica PLC across 6 annual periods. Explore Oxford BioMedica PLC (OXB) long-term investment share to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Oxford BioMedica PLC (2007–2021)
Year-by-year capital reinvestment analysis for Oxford BioMedica PLC. For live market cap and broader valuation context, see Oxford BioMedica PLC market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.74x | GBX18.92 Million | GBX25.45 Million | GBX9.46 Million | ▼ -85.4% |
| 2020 | 5.10x | GBX15.88 Million | GBX3.12 Million | GBX13.36 Million | ▲ +299.5% |
| 2018 | 1.28x | GBX16.42 Million | GBX12.87 Million | GBX10.15 Million | ▼ -53.9% |
| 2017 | 2.77x | GBX8.24 Million | GBX2.98 Million | GBX1.97 Million | ▲ +2122.2% |
| 2009 | 0.12x | GBX288.00K | GBX2.31 Million | GBX288.00K | ▲ +39.8% |
| 2007 | 0.09x | GBX421.00K | GBX4.73 Million | GBX421.00K | — |